Takeda Evotec, Takeda Pharmaceuticals Partner on RNA-Targeting Drug Development The companies will work together to identify and develop small molecule drugs against RNA targets that fit within Takeda's disease areas of focus. UK Biobank Collaborating With Biopharmas to Profile Plasma Proteome of 53K Subjects Led by a group of 10 biopharmaceutical firms, the project will use Olink's proteomic technology to look at participants' plasma levels of roughly 1,500 proteins. Foundation Medicine, Takeda Collaborate to Develop CDx for NSCLC Therapies The tests will be developed to identify NSCLC patients with ALK fusions and EGFR Exon20 insertion mutations who respond to mobocertinib or brigatinib. Twist Bioscience, Takeda Pharma Partner to Develop Antibodies for Oncology, Rare Diseases Twist will give Takeda access to its phage display libraries to help Takeda discover and validate antibodie Takeda's Alunbrig Gets First-Line FDA Approval With Abbott CDx in ALK-Positive Lung Cancer The approval was based on data showing superior efficacy for Alunbrig compared to Pfizer's Xalkori, especially in patients with brain metastasis. Apr 27, 2020 Rockefeller University, Cerevance Pursue Pooled Nuclei Sequencing to Target Brain Cell Types Premium Aug 15, 2019 HiFiBio Bets on Single-Cell Methods to Boost Drug Discovery Premium Oct 9, 2018 ERS Genomics Licenses CRISPR-Cas9 Genome Editing IP to GenAhead Bio May 1, 2018 Thermo Fisher Inks New Pharma Partnerships to Expand CDx Use of Oncomine NGS Test Nov 7, 2016 Takeda Adopts Definiens Biomarker Analysis Platform Sep 12, 2016 HudsonAlpha to Provide Sequencing Services for ORIEN Cancer Initiative Jun 30, 2016 Exosome Diagnostics Inks RNA-Seq Collaboration With Takeda Jun 16, 2016 Takeda, M2Gen Launch Genomic Data Program to Match Patients to Cancer Trials May 28, 2015 Takeda Partners with Sanford-Burnham on Heart Failure Research Jul 16, 2014 Researchers Use APOE-TOMM40 Haplotypes to Explain African-Americans' Unique Alzheimer's Risk Profile Premium Apr 16, 2014 Seattle Genetics Receives Milestone Payments from Takeda for Adcetris Sales Premium Mar 12, 2014 Pharma Slowly Adapting to Complexities and Challenges of Developing Personalized Medicine Premium Sep 4, 2013 Takeda, Zinfandel Launch TOMMORROW Trial to Evaluate Alzheimer's Onset Risk Algorithm, AD-4833 Premium Jul 24, 2013 Takeda, Zinfandel Evaluate Genetic Risk Algorithm Ahead of Alzheimer's Delay Study with Diabetes Rx Premium Jun 19, 2013 Innovation Boom or Bust? Industry Gauges Impact of SCOTUS Ruling on Gene Patents Premium Oct 10, 2012 Alzheimer's Prevention Study in Genetically Defined High-Risk Patients Includes Roche, Lilly Drugs Premium Jul 25, 2012 Rodent Study Suggests Low-Dose Pioglitazone May Improve Cognitive Function in Alzheimer's Patients Premium May 18, 2012 GSK to Buy Cellzome for $99M as Pharma Interest in Chemical Proteomics Continues to Build Premium May 9, 2012 MDx/CDx Focus: AssureRx Launches ADHD PGx Test; Adcetris Phase III Study in CD-30 Lymphoma; CardioDx Premium Apr 17, 2012 Metabolon to Discover, Validate Biomarkers for Takeda Load More Breaking News Sequencing Study Uncovers MERS-Related Coronavirus in Swiss Bats Angstrom Bio Raises $3M in Private Financing Eagle Biosciences, Genetic Analysis Ink Distribution Agreement for Gut Microbiota Test Centogene Q1 Revenues Grow More Than Fivefold Driven by COVID-19 Testing Epizyme Partnering With Quest Diagnostics for Lymphoma Mutation Testing Enzo Biochem, CLX Health Partner to Support COVID-19 Testing for International Travel The Scan CDC Calls Delta "Variant of Concern" CNN reports the US Centers for Disease Control and Prevention now considers the Delta variant of SARS-CoV-2 to be a "variant of concern." From FDA to Venture Capital Former FDA Commissioner Stephen Hahn is taking a position at a venture capital firm, leading some ethicists to raise eyebrows, according to the Washington Post. Consent Questions Nature News writes that there are questions whether informed consent was obtained for some submissions to a database of Y-chromosome profiles. Cell Studies on Multimodal Single-Cell Analysis, Coronaviruses in Bats, Urban Microbiomes In Cell this week: approach to analyze multimodal single-cell genomic data, analysis of bat coronaviruses, and more.